#272 ‒ Rapamycin: potential longevity benefits, surge in popularity, unanswered questions, and more | David Sabatini, M.D., Ph.D. and Matt Kaeberlein, Ph.D.
In this wide-ranging discussion on rapamycin and mTOR, experts delve into the molecule’s promising impact on aging and healthspan, potential mechanisms, and ongoing research endeavors. They explore evidence from various organisms, including humans, on rapamycin’s lifespan-extending effects and discuss strategies to optimize its use. The experts emphasize the need for further research to unlock rapamycin’s full potential and address key questions surrounding its clinical application.
